July – October 2013
Visit the Diopsys Booth at FOA Annual Convention in Daytona Beach, FL! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-pERG Vision Testing Systems can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and pERG Vision Testing Systems, please click here.
Visit the Diopsys Booth at the Vision Trends Annual Meeting in Chicago! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-pERG Vision Testing Systems can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and pERG Vision Testing Systems, please click here.
Visit the Diopsys Booth at the Alabama Optometric Association Gulf Coast Summer Conference! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-ERG (office-based pattern ERG) Vision Testing System can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and ERG Vision Testing System, please click here.
Visit the Diopsys Booth at the National Glaucoma Symposium 2013! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-pERG Vision Testing Systems can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and pERG Vision Testing Systems, please click here.
Visit the Diopsys Booth at the Colorado Vision Summit! Learn more about how the Diopsys®NOVA-VEP and the newly introduced Diopsys® NOVA-ERG (office-based pattern ERG) Vision Testing System can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and ERG Vision Testing System, please click here.
Visit the Diopsys Booth at the SC Optometric Physicians Association Annual Meeting! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-ERG (office-based pattern ERG) Vision Testing System can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and ERG Vision Testing System, please click here.
Visit the Diopsys Booth at the Annual The Banzai Consortium! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-pERG Vision Testing Systems can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and pERG Vision Testing Systems, please click here.
Visit the Diopsys Booth at the NC Society of Eye Physicians and Surgeons Annual Meeting! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-pERG Vision Testing Systems can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and pERG Vision Testing Systems, please click here.
Visit the Diopsys Booth at the EastWest Eye Conference in Cleveland! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-pERG Vision Testing Systems can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and pERG Vision Testing Systems, please click here.
Visit Diopsys Booth #MS5054 at Vision Expo West 2013 in Las Vegas! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-pERG Vision Testing Systems can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and pERG Vision Testing Systems, please click here.
Visit the Diopsys Booth at the COVD 43rd Annual Meeting! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-pERG Vision Testing Systems can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and pERG Vision Testing Systems, please click here.
Visit the Diopsys Booth at the Missouri Optometric Association Annual Conference! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-pERG Vision Testing Systems can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and pERG Vision Testing Systems, please click here.
Visit the Diopsys Booth at Academy 2013 Seattle, the Academy’s 92nd annual meeting! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-pERG vision testing systems can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and pERG Vision Testing Systems, please click here.
Visit the Diopsys Booth at the Annual Michigan Optometric Association Fall Seminar! Learn more about how the Diopsys® NOVA-VEP and the newly introduced Diopsys® NOVA-pERG Vision Testing Systems can benefit your patients and your practice.
Pattern ERG (pERG) has been recognized as an effective, objective test in helping to diagnose maculopathies including age-related macular degeneration (AMD), diabetic edema and the long term toxic effects on retinal health. In conjunction with VEP testing, Diopsys provides vision tests for a complete objective, functional assessment of the visual pathways.
To request more information on the Diopsys® NOVA-VEP and pERG Vision Testing Systems, please click here.
Agenda
Posterboard
Month
Week
Day